Although these results did not reach statistical significance, they offer a potential avenue for improving survival in a subgroup of patients exhibiting relatively low sensitivity.
← all excerpts
Early Ki67 change predicts prognosis and supports response-adapted therapy in breast cancer treated with neoadjuvant chemotherapy.
1
—
—